These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 30145280)

  • 21. Primary Biliary Cholangitis: advances in management and treatment of the disease.
    Invernizzi P; Floreani A; Carbone M; Marzioni M; Craxi A; Muratori L; Vespasiani Gentilucci U; Gardini I; Gasbarrini A; Kruger P; Mennini FS; Ronco V; Lanati E; Canonico PL; Alvaro D
    Dig Liver Dis; 2017 Aug; 49(8):841-846. PubMed ID: 28546061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ursodeoxycholic acid and artesunate in the treatment of severe falciparum malaria patients with jaundice.
    Treeprasertsuk S; Silachamroon U; Krudsood S; Huntrup A; Suwannakudt P; Vannaphan S; Wilairatana P
    J Gastroenterol Hepatol; 2010 Feb; 25(2):362-8. PubMed ID: 19817958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis.
    Jacquemin E; Hermans D; Myara A; Habes D; Debray D; Hadchouel M; Sokal EM; Bernard O
    Hepatology; 1997 Mar; 25(3):519-23. PubMed ID: 9049190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrahepatic cholestasis of pregnancy: a case report.
    Konjeti R; Selsky N
    Conn Med; 2012 Mar; 76(3):163-4. PubMed ID: 22666977
    [No Abstract]   [Full Text] [Related]  

  • 25. Stratified medicine and primary biliary cholangitis.
    Mells GF; Jones DE
    Lancet Gastroenterol Hepatol; 2017 May; 2(5):319-321. PubMed ID: 28397694
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of autoimmune cholangitis.
    Mohr L; Heintges T; Hensel F; Niederau C; Häussinger D
    Dig Dis Sci; 1998 Sep; 43(9):2160-3. PubMed ID: 9753287
    [No Abstract]   [Full Text] [Related]  

  • 27. Recurrent intrahepatic cholestasis of pregnancy: ursodeoxycholic acid should be the first line of treatment.
    Jain P
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):479-80. PubMed ID: 19104716
    [No Abstract]   [Full Text] [Related]  

  • 28. Adjuvant treatment with ursodeoxycholic acid reduces acute rejection after liver transplantation.
    Friman S; Persson H; Scherstén T; Svanvik J; Karlberg I
    Transpl Int; 1992; 5 Suppl 1():S187-9. PubMed ID: 14621771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toward precision medicine in primary biliary cholangitis.
    Carbone M; Ronca V; Bruno S; Invernizzi P; Mells GF
    Dig Liver Dis; 2016 Aug; 48(8):843-50. PubMed ID: 27324985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis and treatment of intrahepatic cholestasis in chronic diseases of the liver].
    Golovanova EV; Petrakov AV
    Ter Arkh; 2011; 83(2):33-9. PubMed ID: 21516847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Jeune syndrome and liver disease: report of three cases treated with ursodeoxycholic acid.
    Labrune P; Fabre M; Trioche P; Estournet-Mathiaud B; Grangeponte MC; Rambaud C; Maurage C; Bernard O
    Am J Med Genet; 1999 Dec; 87(4):324-8. PubMed ID: 10588838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relative expression of hepatocellular and cholestatic liver enzymes in adult patients with liver disease.
    Iluz-Freundlich D; Zhang M; Uhanova J; Minuk GY
    Ann Hepatol; 2020; 19(2):204-208. PubMed ID: 31628070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase.
    Murillo Perez CF; Harms MH; Lindor KD; van Buuren HR; Hirschfield GM; Corpechot C; van der Meer AJ; Feld JJ; Gulamhusein A; Lammers WJ; Ponsioen CY; Carbone M; Mason AL; Mayo MJ; Invernizzi P; Battezzati PM; Floreani A; Lleo A; Nevens F; Kowdley KV; Bruns T; Dalekos GN; Gatselis NK; Thorburn D; Trivedi PJ; Verhelst X; Parés A; Janssen HLA; Hansen BE;
    Am J Gastroenterol; 2020 Jul; 115(7):1066-1074. PubMed ID: 32618657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune cholangitis presented as fever of unknown origin.
    Petrogiannopoulos C; Papamichael K; Karachalios G; Karachaliou I; Kostakos N; Barbati K; Zacharof A
    Chemotherapy; 2006; 52(6):282-4. PubMed ID: 17008778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ursodeoxycholic acid treatment in intrahepatic cholestasis of pregnancy. A case report].
    Lengyel G; Fehér R; Gardó S; Fehér J
    Orv Hetil; 2002 Dec; 143(52):2885-8. PubMed ID: 12638316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases.
    Trauner M; Graziadei IW
    Aliment Pharmacol Ther; 1999 Aug; 13(8):979-96. PubMed ID: 10468672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of ursodeoxycholic acid on chronic intrahepatic cholestasis due to sarcoidosis.
    Bécheur H; Dall'osto H; Chatellier G; Charton-Bain MC; Aubertin JM; Attar A; Bloch F; Petite JP
    Dig Dis Sci; 1997 Apr; 42(4):789-91. PubMed ID: 9125650
    [No Abstract]   [Full Text] [Related]  

  • 38. Primary biliary cholangitis: a comprehensive overview.
    Lleo A; Marzorati S; Anaya JM; Gershwin ME
    Hepatol Int; 2017 Nov; 11(6):485-499. PubMed ID: 29164395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of ursodeoxycholic acid in liver diseases.
    Kumar D; Tandon RK
    J Gastroenterol Hepatol; 2001 Jan; 16(1):3-14. PubMed ID: 11206313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New name and new treatments for primary biliary cholangitits].
    Bossen L; Ytting H; Jepsen P; Hamberg O; Ott P; Grønbæk H
    Ugeskr Laeger; 2018 Mar; 180(10):. PubMed ID: 29536837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.